Czechia· CZ-0222462
SYMTUZA
A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing darunavir ethanolate + cobicistat + emtricitabine + tenofovir alafenamide fumarate, registered in Czechia by Janssen-Cilag International N.V., Beerse. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- DARUNAVIR ETHANOLATE + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDE FUMARATE
- Manufacturer
- Janssen-Cilag International N.V., Beerse
- Country
- Czechia (CZ)
- ATC code
- J05AR22
- ATC class
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl022246230CZK 22437.57
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandSymtuzaOrifarm Oy
- IrelandSymtuza 800 mg/150 mg/200 mg/10 mg film-coated tabletsJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/41cbb6d6-d0b2-4ada-ad13-211f84aa1583 GET /v1/drugs/41cbb6d6-d0b2-4ada-ad13-211f84aa1583?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "800MG/150MG/200MG/10MG",
"pack_size": "30",
"substance": "DARUNAVIR ETHANOLATE + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDE FUMARATE",
"cz_kod_sukl": "0222462",
"product_type": "CH",
"substance_codes": "17866,19000,15579,20936",
"registration_state": "R",
"registration_number": "EU/1/17/1225/001"
}See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.